Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunomodulatory Drugs”

56 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 56 results

Not applicableLooking for participantsNCT07033663
What this trial is testing

Impact of In Utero Exposure to Immunomodulatory Drugs on Neonatal Immune System Development

Who this might be right for
Pregnancy RelatedImmune-mediated Diseases
Fundació Sant Joan de Déu 90
Post-approval studies (Phase 4)Enrolling By InvitationNCT06635863
What this trial is testing

Comparing Immune System Suppression to Medication for Unexplained Heart Function and Irregular Heartbeat

Who this might be right for
Ventricular ArrythmiaNon-ischemic CardiomyopathyArrhythmogenic Inflammatory Cardiomyopathy
Roderick Tung 40
Not applicableStudy completedNCT03530215
What this trial is testing

Evaluation of Reporting of Cardio-vascular Adverse Events With Antineoplastic and Immunomodulating Agents (EROCA)

Who this might be right for
Cardiac DiseaseCancer
Groupe Hospitalier Pitie-Salpetriere 500,000
Early research (Phase 1)Study completedNCT01998971
What this trial is testing

JNJ-54767414 (HuMax CD38) (Anti-CD38 Monoclonal Antibody) in Combination With Backbone Treatments for the Treatment of Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 240
Testing effectiveness (Phase 2)Study completedNCT03525678
What this trial is testing

Investigate the Efficacy and Safety of Two Doses of GSK2857916 in Participants With Multiple Myeloma Who Have Failed Prior Treatment With an Anti-CD38 Antibody

Who this might be right for
Multiple Myeloma
GlaxoSmithKline 221
Post-approval studies (Phase 4)Study completedNCT00735072
What this trial is testing

Maraviroc as an Immunomodulatory Drug for Antiretroviral-treated HIV Infected Patients Exhibiting Immunologic Failure

Who this might be right for
HIV Infection
University of California, San Francisco 45
Early research (Phase 1)Study completedNCT03269136
What this trial is testing

PF-06863135 As Single Agent And In Combination With Immunomodulatory Agents In Relapse/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Pfizer 101
Early research (Phase 1)Study completedNCT04447027
What this trial is testing

Romidepsin, CC-486 (5-azacitidine), Dexamethasone, and Lenalidomide (RAdR) for Relapsed/Refractory T-cell Malignancies

Who this might be right for
Cutaneous T-Cell LymphomaMature T-cell MalignanciesPeripheral T-Cell Lymphoma+1 more
National Cancer Institute (NCI) 26
Early research (Phase 1)Study completedNCT02892318
What this trial is testing

A Study Evaluating the Safety and Pharmacology of Atezolizumab Administered in Combination With Immunomodulatory Agents in Participants With Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
Hoffmann-La Roche 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT04764942
What this trial is testing

Selinexor, Pomalidomide, and Dexamethasone With or Without Carfilzomib for the Treatment of Patients With Relapsed Refractory Multiple Myeloma, The SCOPE Trial

Who this might be right for
Recurrent Multiple MyelomaRefractory Multiple Myeloma
Mayo Clinic 39
Testing effectiveness (Phase 2)WithdrawnNCT06767956
What this trial is testing

Golcadomide and Nivolumab in Patients With Non-Hodgkin Lymphoma With Refractory Disease After Chimeric Antigen T-cell Therapy

Who this might be right for
Non Hodgkin Lymphoma
University of Pittsburgh
Testing effectiveness (Phase 2)Ended earlyNCT05288062
What this trial is testing

Immunomodulatory Drugs (Lenalidomide With or Without Pomalidomide) in Combination With a Corticosteroid Drug (Dexamethasone) for the Treatment of Multiple Myeloma

Who this might be right for
Plasma Cell MyelomaRecurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma+1 more
Mayo Clinic 17
Not applicableStudy completedNCT01879046
What this trial is testing

Regenerative Medicine of Articular Cartilage: Characterization and Comparison of Chondrogenic Potential and Immunomodulatory Adult Mesenchymal Stem Cells

Who this might be right for
Knee Osteoarthritis
Nantes University Hospital 35
Testing effectiveness (Phase 2)Active Not RecruitingNCT04124497
What this trial is testing

A Trial for Relapsed and Relapsed/Refractory Multiple Myeloma Patients

Who this might be right for
Multiple MyelomaDeletion 17P Syndrome
Fondazione EMN Italy Onlus 45
Testing effectiveness (Phase 2)Study completedNCT02654990
What this trial is testing

Panobinostat/Bortezomib/Dexamethasone in Relapsed or Relapsed-and-refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
pharmaand GmbH 248
Not applicableStudy completedNCT06264206
What this trial is testing

Effect of Immunomodulatory Treatment on IVF (in Vitro Fertilization) Outcomes in Patients With KIR AA Genotype

Who this might be right for
Immunomodulatory DrugsKiller-cell Immunoglobulin-like Receptors (KIRs)KIR Alleles (KIR AA)
Calla IVF Center 65
Not applicableStudy completedNCT00229502
What this trial is testing

Cognitive Effects of Immunomodulatory Drugs in MS

Who this might be right for
Multiple Sclerosis
Sharon Lynch, MD 96
Large-scale testing (Phase 3)UnknownNCT05489900
What this trial is testing

Immunomodulatory Effect of Dexmedetomidine as an Adjuvant Drug in Laparoscopic Cholecystectomies

Who this might be right for
Physiological Effects of Drugs
Universidade Federal do Rio de Janeiro 52
Not applicableStudy completedNCT06054438
What this trial is testing

Examining the Function of Cs4 on Post-COVID-19 Disorders

Who this might be right for
Long COVID
The University of Hong Kong 110
Large-scale testing (Phase 3)WithdrawnNCT05461209
What this trial is testing

Comparing Talquetamab to Belantamab Mafodotin in Participants With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed/ Refractory Multiple Myeloma
Janssen Research & Development, LLC
Next Page